These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28809804)

  • 21. Influence of light alcohol consumption on lifestyle-related diseases: a predictor of fatty liver with liver enzyme elevation in Japanese females with metabolic syndrome.
    Sogabe M; Okahisa T; Nakagawa T; Fukuno H; Nakasono M; Tomonari T; Tanaka T; Tanaka H; Taniguchi T; Muguruma N; Takayama T
    BMC Gastroenterol; 2016 Feb; 16():17. PubMed ID: 26892109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum alanine aminotransferase predicts interventricular septum thickness and left ventricular mass in patients with nonalcoholic fatty liver disease.
    Ybarra J; Fernández S; Sánchez-Hernández J; Romeo JH; Ballesta-Lopez C; Guell J; Mearin F
    Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):654-60. PubMed ID: 24667349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes.
    de Vries M; El-Morabit F; van Erpecum KJ; Westerink J; Bac ST; Kaasjager HAHK; de Valk HW
    Eur J Intern Med; 2022 Jun; 100():77-82. PubMed ID: 35387749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic determinants of NAFLD in adults with type 1 diabetes.
    Serdarova M; Dimova R; Chakarova N; Grozeva G; Todorova A; Tsarkova P; Marinova C; Popov D; Mateva L; Tankova T
    Diabetes Res Clin Pract; 2022 Apr; 186():109819. PubMed ID: 35248654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese Children.
    Song P; Yu J; Wang M; Chang X; Wang J; An L
    Int J Environ Res Public Health; 2017 Apr; 14(5):. PubMed ID: 28448433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of Lean Patients with Non-alcoholic Fatty Liver Disease in a Middle Income Country; Prevalence and Its Association with Metabolic Disorders: A Cross-sectional Study.
    Naderian M; Kolahdoozan S; Sharifi AS; Garmaroudi G; Yaseri M; Poustchi H; Sohrabpour AA
    Arch Iran Med; 2017 Apr; 20(4):211-217. PubMed ID: 28412824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori infection is not associated with fatty liver disease including non-alcoholic fatty liver disease: a large-scale cross-sectional study in Japan.
    Okushin K; Takahashi Y; Yamamichi N; Shimamoto T; Enooku K; Fujinaga H; Tsutsumi T; Shintani Y; Sakaguchi Y; Ono S; Kodashima S; Fujishiro M; Moriya K; Yotsuyanagi H; Mitsushima T; Koike K
    BMC Gastroenterol; 2015 Feb; 15():25. PubMed ID: 25880912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of nonalcoholic fatty liver disease and its metabolic risk factors in women of different ages and body mass index.
    Wang Z; Xu M; Hu Z; Shrestha UK
    Menopause; 2015 Jun; 22(6):667-73. PubMed ID: 25513983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and Profile of Fibrosis in Diabetic Patients with Non-alcoholic Fatty Liver Disease and the Associated Factors.
    Prasetya IB; Hasan I; Wisnu W; Rumende CM
    Acta Med Indones; 2017 Apr; 49(2):91-98. PubMed ID: 28790222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-alcoholic fatty liver disease in diabetics--prevalence and predictive factors in a multiracial hospital clinic population in Malaysia.
    Chan WK; Tan AT; Vethakkan SR; Tah PC; Vijayananthan A; Goh KL
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1375-83. PubMed ID: 23517307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.
    Olusanya TO; Lesi OA; Adeyomoye AA; Fasanmade OA
    Pan Afr Med J; 2016; 24():20. PubMed ID: 27583084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-alcoholic fatty liver disease and its associated risk factors in Brazilian postmenopausal women.
    Bruno Ade S; Rodrigues MH; Alvares MC; Nahas-Neto J; Nahas EA
    Climacteric; 2014 Aug; 17(4):465-71. PubMed ID: 24517420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Criteria Correlated with the Incidence of Patients with Non-alcoholic Fatty Liver Disease.
    Chien-Min K; Cheng-Chuan L
    Ann Clin Lab Sci; 2017 Mar; 47(2):191-200. PubMed ID: 28442522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease (NAFLD) in different populations: A clinical and epidemiological study - sample of São José do Rio Preto.
    Andrade GC; Fujise LH; Santana JE; Oliveira F; Silva Rde C
    Rev Assoc Med Bras (1992); 2016; 62(3):218-26. PubMed ID: 27310544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
    Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
    Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between ultrasound features of nonalcoholic fatty liver disease and cardiometabolic risk factors in patients with newly diagnosed type 2 diabetes.
    Kosmalski M; Kasznicki J; Drzewoski J
    Pol Arch Med Wewn; 2013; 123(9):436-42. PubMed ID: 23792440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes.
    Käräjämäki AJ; Bloigu R; Kauma H; Kesäniemi YA; Koivurova OP; Perkiömäki J; Huikuri H; Ukkola O
    Metabolism; 2017 Jan; 66():55-63. PubMed ID: 27423871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.